34 insiders have filed at INCY since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Baker Brothers Life Sciences Lp | Director | 28.78M | 13.916% | ||
| 667, L.P. | Director | 28.78M | 13.916% | ||
| Baker Felix | Director | 28.78M | 13.916% | ||
| Baker Bros. Advisors Lp | Director | 28.78M | 13.916% | ||
| Baker Bros. Advisors (gp) Llc | Director | 28.78M | 13.916% | ||
| Baker Julian | Director | 28.78M | 13.916% | ||
| Hoppenot Herve | Director | 326.8k | 0.158% | 1 sells $19.8M | |
| Cagnoni Pablo J | President, R&d | 234.8k | 0.114% | 2 sells $3.6M | |
| Stamoulis Christiana | EVP & Chief Financial Officer | 125.8k | 0.061% | ||
| Swain Paula J | EVP, Human Resources | 106.5k | 0.051% | 1 sells $550k | |
| Pasquale Maria E | EVP & General Counsel | 69.7k | 0.034% | ||
| Issa Mohamed Khairie | EVP, Head Of Us Oncology | 66.1k | 0.032% | 1 sells $1.2M | |
| Mayes Patrick A | EVP & Chief Scientific Officer | 60.0k | 0.029% | 2 sells $555k | |
| Dhanak Dashyant | EVP & Chief Scientific Officer | 59.0k | 0.029% | ||
| Iyengar Vijay K | EVP, Gmapps | 40.5k | 0.02% | 8 sells $2.3M | |
| Heeson Lee | EVP, Head Of Incyte Intl | 38.0k | 0.018% | 1 sells $289k | |
| Dickinson Jonathan Elliott | EVP, General Manager, Europe | 36.4k | 0.018% | 2 sells $527k | |
| Meury William | Chief Executive Officer | 36.1k | 0.017% | ||
| Flannelly Barry P | EVP & General Manager Us | 35.1k | 0.017% | 11 sells $4.3M | |
| Stein Steven H | EVP & Chief Medical Officer | 34.2k | 0.017% | 10 sells $9.2M | |
| Morrissey Michael James | EVP, Head Of Tech. Operations | 34.1k | 0.016% | 3 sells $5.7M | |
| Denton Sheila A. | EVP & General Counsel | 26.6k | 0.013% | 16 sells $2.1M | |
| Clancy Paul J | Director | 23.5k | 0.011% | ||
| Tray Thomas | Principal Accounting Officer | 23.0k | 0.011% | 13 sells $815k | |
| Harrigan Edmund | Director | 20.9k | 0.01% | ||
| Bienaime Jean Jacques | Director | 20.8k | 0.01% | ||
| Fouse Jacqualyn A | Director | 19.3k | <0.01% | ||
| Trotta Matteo | EVP, Gm, Dermatology Us | 14.9k | <0.01% | ||
| High Katherine A | Director | 13.3k | <0.01% | ||
| Brawley Otis W | Director | 11.3k | <0.01% | ||
| Hoffman Richard A. | EVP & General Counsel | 9.5k | <0.01% | ||
| Gardner David H | EVP, Chief Strategy Officer | 9.4k | <0.01% | ||
| Schaffert Susanne | Director | 7.4k | <0.01% | ||
| Basi Ramitpal K | EVP, Human Resources | 6.5k | <0.01% |
Full register at boothcheck.com/insiders/INCY. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.